Authors:
Seehofer, D
Rayes, N
Steinmuller, T
Muller, AR
Settmacher, U
Neuhaus, R
Radke, C
Berg, T
Hopf, U
Neuhaus, P
Citation: D. Seehofer et al., Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation, LIVER TRANS, 7(11), 2001, pp. 976-982
Authors:
Settmacher, U
Steinmuller, T
Heise, M
Nussler, NC
Schon, M
Neuhaus, P
Citation: U. Settmacher et al., Simultaneous carotid artery reconstruction in patients undergoing other surgical interventions, LANG ARCH S, 386(4), 2001, pp. 257-260
Authors:
Jonas, S
Bechstein, WO
Steinmuller, T
Herrmann, M
Radke, C
Berg, T
Settmacher, U
Neuhaus, P
Citation: S. Jonas et al., Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis, HEPATOLOGY, 33(5), 2001, pp. 1080-1086
Authors:
Jonas, S
Guckelberger, O
Tullius, SG
Steinmuller, T
Muller, AR
Grauhan, O
Langrehr, JM
Bechstein, WO
Neuhaus, P
Citation: S. Jonas et al., Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy, TRANSPLAN P, 33(3), 2001, pp. 2232-2233
Authors:
Ulrich, F
Steinmuller, T
Rayes, N
Kleespiess, A
Grzonka, S
Gerlach, J
Neuhaus, P
Citation: F. Ulrich et al., Cryopreserved human parathyroid tissue: Cell cultures for in vitro testingof function, TRANSPLAN P, 33(1-2), 2001, pp. 666-667
Authors:
Mueller, AR
Platz, KP
Willimski, C
Berg, T
Steinmuller, T
Neumann, U
Neuhaus, R
Hopf, U
Radke, C
Neuhaus, P
Citation: Ar. Mueller et al., Influence of immunosuppression on patient survival after liver transplantation for hepatitis C, TRANSPLAN P, 33(1-2), 2001, pp. 1347-1349
Authors:
Pfitzmann, R
Langrehr, JM
Heise, M
Steinmuller, T
Neuhaus, R
Neuhaus, P
Citation: R. Pfitzmann et al., Successful orthotopic liver transplantation for treatment of intrahepatic Osler's disease, TRANSPLAN P, 33(1-2), 2001, pp. 1426-1427
Authors:
Langrehr, JM
Lohmann, R
Guckelberger, O
Muller, AR
Raakow, R
Nussler, NC
Klupp, J
Pfitzmann, R
Jonas, S
Settmacher, U
Steinmuller, T
Neuhaus, P
Citation: Jm. Langrehr et al., IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1433-1434
Authors:
Langrehr, JM
Klupp, J
Pfitzmann, R
Neumann, U
Lohmann, R
Jonas, S
Neuhaus, R
Steinmuller, T
Neuhaus, P
Citation: Jm. Langrehr et al., A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1520-1520
Authors:
Rayes, N
Seehofer, D
Schmidt, CA
Muller, AR
Steinmuller, T
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment?, TRANSPLAN P, 33(1-2), 2001, pp. 1804-1804
Authors:
Seehofer, D
Rayes, N
Naumann, U
Neuhaus, R
Muller, AR
Tullius, SG
Berg, T
Steinmuller, T
Bechstein, WO
Neuhaus, P
Citation: D. Seehofer et al., Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation, TRANSPLANT, 72(8), 2001, pp. 1381-1385
Authors:
Rayes, N
Seehofer, D
Schmidt, CA
Oettle, H
Muller, AR
Steinmuller, T
Settmacher, U
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation., TRANSPLANT, 72(5), 2001, pp. 881-885
Authors:
Pfitzmann, R
Heise, M
Langrehr, JM
Jonas, S
Steinmuller, T
Podrabsky, P
Ewert, R
Settmacher, U
Neuhaus, R
Neuhaus, P
Citation: R. Pfitzmann et al., Liver transplantation for treatment of intrahepatic Osler's disease: Firstexperiences, TRANSPLANT, 72(2), 2001, pp. 237-241